Pharma Ad Ban Legislation Has Slim Chances, TD Cowen Says

June 12, 2025, 7:52 PM UTC

TD Cowen analyst Rick Weissenstein says Senator Bernie Sanders and Senator Angus King’s bill to stop pharmaceutical direct-to-consumer advertising is unlikely to prevail.

READ: AbbVie Slumps on Report of Proposal to Ban Drug Advertising

  • The bill would ban prescription drug advertising on television, radio, print, digital platforms and social media, the analyst notes
  • “Short of a significant push by President Trump, we think there is little chance the bill will pass,” he writes
  • Analyst notes that the bill currently only has nine co-sponsors and similar bills in the past have not been passed
  • “We believe any efforts to ban ...



Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.